Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'Efficacy of Yang Shen Dan in Mild to Moderate Alzheimer’s Disease: Randomised controlled study'. The following are the other relevant details related to the trial:
Therapeutic Area: Neurology
Trial Centre(s):
National Neuroscience Institute
Singapore General Hospital
Trial Status: NA
Principal Investigator(s):
Dr Adeline Ng Su Lyn
Dr Simon Ting Kang Seng
Published by HT Digital Content Services with permission from Health Daily Digest....